We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
-13.93%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.44B
AUM Growth
-$266M
(-16%)
Cap. Flow
-$4.59M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
33.34%
Holding
325
New
10
Increased
75
Reduced
47
Closed
24
Avg Time Held
3.1
years
Top 10 Avg Time Held
3.5
years
Top 20 Avg Time Held
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$598K |
| 2 |
Teleflex
TFX
|
+$547K |
| 3 |
GoDaddy
GDDY
|
+$471K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$452K |
| 5 |
Xometry
XMTR
|
+$416K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$999K |
| 2 |
Citigroup
C
|
+$675K |
| 3 |
W.R. Berkley
WRB
|
+$655K |
| 4 |
Carlisle Companies
CSL
|
+$506K |
| 5 |
WillScot Mobile Mini Holdings
WSC
|
+$502K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Industrials | 16.41% |
| 3 | Healthcare | 12.77% |
| 4 | Financials | 11.85% |
| 5 | Communication Services | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.99T
| $98M | 6.79% |
716,474
-159
| -0% | -$24.1K |
2016 Q1
25 quarters
|
|
2
Microsoft
MSFT
$4.01T
| $48.5M | 3.36% |
188,649
-78
| -0% | -$21.2K |
2016 Q1
25 quarters
|
|
3
Union Pacific
UNP
$172B
| $47.3M | 3.28% |
221,739
-182
| -0.1% | -$41.4K |
2016 Q1
25 quarters
|
|
4
Thermo Fisher Scientific
TMO
$258B
| $45.7M | 3.17% |
84,160
| – | – |
2016 Q1
25 quarters
|
|
5
Automatic Data Processing
ADP
$113B
| $42.7M | 2.96% |
203,462
| – | – |
2016 Q1
25 quarters
|
|
6
Eli Lilly
LLY
$1.12T
| $42.5M | 2.94% |
130,976
| – | – |
2016 Q1
25 quarters
|
|
7
Blackrock
BLK
$174B
| $41.6M | 2.88% |
68,284
-32
| -0% | -$20.8K |
2016 Q1
25 quarters
|
|
8
Salesforce
CRM
$203B
| $39.7M | 2.75% |
240,400
| – | – |
2016 Q1
25 quarters
|
|
9
JPMorgan Chase
JPM
$891B
| $39.3M | 2.72% |
348,692
+606
| +0.2% | +$75.1K |
2016 Q1
25 quarters
|
|
10
RTX Corp
RTX
$252B
| $36M | 2.5% |
374,679
| – | – |
2016 Q1
25 quarters
|
|
11
Pfizer
PFE
$168B
| $34.9M | 2.42% |
665,260
| – | – |
2016 Q1
25 quarters
|
|
12
Home Depot
HD
$308B
| $33.5M | 2.32% |
121,988
-415
| -0.3% | -$123K |
2016 Q1
25 quarters
|
|
13
General Dynamics
GD
$91.2B
| $31.8M | 2.2% |
143,524
+1,374
| +1% | +$316K |
2016 Q1
25 quarters
|
|
14
McDonald's
MCD
$172B
| $31.7M | 2.2% |
128,519
| – | – |
2016 Q1
25 quarters
|
|
15
Alphabet (Google) Class C
GOOG
$4.22T
| $31.3M | 2.17% |
285,860
| – | – |
2016 Q1
25 quarters
|
|
16
Alphabet (Google) Class A
GOOGL
$4.27T
| $31.2M | 2.16% |
286,360
-160
| -0.1% | -$18.8K |
2016 Q1
25 quarters
|
|
17
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $31.1M | 2.15% |
75,150
| – | – |
2016 Q1
25 quarters
|
|
18
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.1B
| $26.5M | 1.84% |
177,150
| – | – |
2021 Q1
5 quarters
|
|
19
Walmart Inc
WMT
$935B
| $24.9M | 1.73% |
615,195
-195
| -0% | -$8.99K |
2016 Q1
25 quarters
|
|
20
Honeywell
HON
$66.7B
| $24.9M | 1.72% |
151,802
+351
| +0.2% | +$63K |
2016 Q1
25 quarters
|
|
21
Amazon
AMZN
$2.75T
| $23.6M | 1.64% |
222,600
| – | – |
2016 Q1
25 quarters
|
|
22
ExxonMobil
XOM
$718B
| $22.8M | 1.58% |
266,000
| – | – |
2020 Q1
9 quarters
|
|
23
CVS Health
CVS
$118B
| $22.7M | 1.57% |
245,059
| – | – |
2016 Q1
25 quarters
|
|
24
Meta Platforms (Facebook)
META
$1.88T
| $22.6M | 1.57% |
140,330
| – | – |
2016 Q1
25 quarters
|
|
25
Walt Disney
DIS
$191B
| $22.2M | 1.54% |
234,850
-2,087
| -0.9% | -$232K |
2020 Q4
6 quarters
|
|
Similar funds
Henshaw Capital's Q2 2022 Portfolio in Review
As of Q2 2022, Henshaw Capital held 325 positions worth $1.44B, down 16% from $1.71B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Henshaw Capital's Q2 2022 filing shows 10 new, 75 increased, 47 reduced and 24 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,930 shares worth $457K. The largest sale was Dentsply Sirona, an estimated $999K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.
- Henshaw Capital's largest Q2 2022 buy was Bristol-Myers Squibb: 5,930 shares worth $457K.
- Henshaw Capital added most to Burlington in Q2 2022, an estimated $598K increase.
- Henshaw Capital's biggest Q2 2022 reduction was Citigroup, cutting an estimated $675K.
- Henshaw Capital fully exited Dentsply Sirona in Q2 2022, selling an estimated $999K.
- Henshaw Capital's ten largest holdings make up 33% of its $1.44B portfolio in Q2 2022.
- Henshaw Capital opened 10 new positions and closed 24 in Q2 2022.
- Henshaw Capital's portfolio value fell 16% quarter-over-quarter to $1.44B.
Based on Henshaw Capital's 13F filing for Q2 2022, filed 28 May 2026.